New tool aims to boost vaccine uptake in Hard-to-Reach communities
NCT ID NCT05866237
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tested a patient engagement tool (PET) designed to encourage COVID-19 and flu vaccination among underserved populations in East London, including minority ethnic groups, migrants, and low-income individuals. Over 5,900 adults from six GP practices were randomly assigned to receive the PET or standard care. The tool provided culturally adapted educational messages via text, video, or voice. The main goal was to see if the tool increased vaccination rates and was acceptable to patients.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Patient Engagement Tool (PET) - a culturally adapted educational messaging system (text, video, or voice)
- What this could lead to
- If successful, this approach could help increase vaccination rates in underserved communities, reducing health disparities.
- What could go wrong
- This is a pilot study focused on feasibility, not a large-scale trial. The tool may not work in other regions or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Church Road Health
London, E12 6AQ, United Kingdom
-
Glen Road Surgery
London, United Kingdom
-
St Andrews Health Centre/ St Pauls Way Health Centre
London, United Kingdom
-
St Stephen's Health Centre
London, United Kingdom
-
Stratford Village Health Centre
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?